These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19595354)

  • 1. Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects.
    Guaraldi G; Stentarelli C; Zona S; Orlando G; Carli F; Ligabue G; Lattanzi A; Zaccherini G; Rossi R; Modena MG; Alexopoulos N; Palella F; Raggi P
    Atherosclerosis; 2010 Jan; 208(1):222-7. PubMed ID: 19595354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients.
    Guaraldi G; Scaglioni R; Zona S; Orlando G; Carli F; Ligabue G; Besutti G; Bagni P; Rossi R; Modena MG; Raggi P
    AIDS; 2011 Jun; 25(9):1199-205. PubMed ID: 21505301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy.
    Chuapai Y; Kiertiburanakul S; Malathum K; Sungkanuparph S
    J Med Assoc Thai; 2007 Mar; 90(3):452-8. PubMed ID: 17427520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV.
    Zona S; Raggi P; Bagni P; Orlando G; Carli F; Ligabue G; Scaglioni R; Rossi R; Modena MG; Guaraldi G
    Am Heart J; 2012 Jun; 163(6):1024-30. PubMed ID: 22709756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary aging in HIV-infected patients.
    Guaraldi G; Zona S; Alexopoulos N; Orlando G; Carli F; Ligabue G; Fiocchi F; Lattanzi A; Rossi R; Modena MG; Esposito R; Palella F; Raggi P
    Clin Infect Dis; 2009 Dec; 49(11):1756-62. PubMed ID: 19886793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse correlation between vascular calcification and bone mineral density in human immunodeficiency virus-infected patients.
    Bellasi A; Zona S; Orlando G; Carli F; Ligabue G; Rochira V; Santoro A; Mussini C; Guaraldi G; Raggi P
    Calcif Tissue Int; 2013 Nov; 93(5):413-8. PubMed ID: 23975212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus infection is associated with accelerated atherosclerosis.
    Guaraldi G; Zona S; Orlando G; Carli F; Ligabue G; Fiocchi F; Menozzi M; Rossi R; Modena MG; Raggi P
    J Antimicrob Chemother; 2011 Aug; 66(8):1857-60. PubMed ID: 21653601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.
    van Griensven J; De Naeyer L; Mushi T; Ubarijoro S; Gashumba D; Gazille C; Zachariah R
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):793-8. PubMed ID: 17467756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy.
    Kinabo GD; Sprengers M; Msuya LJ; Shayo AM; van Asten H; Dolmans WM; van der Ven AJ; Warris A
    Pediatr Infect Dis J; 2013 Jan; 32(1):39-44. PubMed ID: 23038217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent association of subclinical coronary artery disease and emphysema in HIV-infected patients.
    Besutti G; Raggi P; Zona S; Scaglioni R; Santoro A; Orlando G; Ligabue G; Leipsic J; Sin DD; Man SF; Guaraldi G
    HIV Med; 2016 Mar; 17(3):178-87. PubMed ID: 26268373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients.
    Freitas P; Carvalho D; Santos AC; Madureira AJ; Xerinda S; Martinez E; Pereira J; Sarmento A; Medina JL
    J Clin Hypertens (Greenwich); 2012 Sep; 14(9):593-600. PubMed ID: 22947357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
    Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
    Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study.
    Kingsley LA; Cuervo-Rojas J; Muñoz A; Palella FJ; Post W; Witt MD; Budoff M; Kuller L
    AIDS; 2008 Aug; 22(13):1589-99. PubMed ID: 18670218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: the role of monocyte chemoattractant protein-1.
    Coll B; Parra S; Alonso-Villaverde C; de Groot E; Aragonés G; Montero M; Tous M; Camps J; Joven J; Masana L
    Cytokine; 2006 Apr; 34(1-2):51-5. PubMed ID: 16697654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
    Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
    Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.